Nyxoah SA

Medical Instruments & Supplies • Healthcare • Mont-Saint-Guibert, Belgium • NYXH (NGM)

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Yahoo Finance • Oct 29

Earnings call transcript: Nyxoah Q3 2025 sees revenue miss, stock slides - Investing.com

Investing.com • Nov 13

Nyxoah (NASDAQ:NYXH) Trading Down 2.9% - Here's What Happened - MarketBeat

MarketBeat • Dec 13

New battery-free sleep apnea implant debuts in Dutch hospitals - Stock Titan

Stock Titan • Dec 17

Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - Stocktwits

Stocktwits • Nov 26

Other Medical Instruments & Supplies Companies

View All →

Intuitive Surgical Inc.

$206.27B market cap

Becton Dickinson & Co.

WEST Pharmaceutical Services Inc.

$19.83B market cap

Frequently Asked Questions

Has Nyxoah SA had layoffs?

No layoff events have been recorded for Nyxoah SA in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Nyxoah SA have?

Nyxoah SA has approximately 183 employees.

What industry is Nyxoah SA in?

Nyxoah SA operates in the Medical Instruments & Supplies industry, within the Healthcare sector.

Is Nyxoah SA a publicly traded company?

Yes, Nyxoah SA is publicly traded under the ticker symbol NYXH on the NGM. The company has a market capitalization of approximately $0.20 billion.

Where is Nyxoah SA headquartered?

Nyxoah SA is headquartered in Mont-Saint-Guibert, Belgium.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.